Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant-Reference-Cited by-同舟云学术

Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant

Published:2019-10-28 Issue:4 Volume:55 Page:773-779
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ryan Anne L.,Wadia Ushma D.,Jacoby Peter,Cheung Laurence C.^ORCID,Kerr Fiona,Fraser Chris,Tapp Heather,Mechinaud Francoise,Carolan Louise A.,Laurie Karen L.,Barr Ian G.,Blyth Christopher C.,Gottardo Nicholas G.,Richmond Peter C.,Kotecha Rishi S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0728-5.pdf

Reference28 articles.

1. Ljungman P, Ward KN, Crooks BN, Parker A, Martino R, Shaw PJ, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28:479–84.

2. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;39:1300–6.

3. Fisher BT, Danziger-Isakov L, Sweet LR, Munoz FM, Maron G, Tuomanen E, et al. A multicenter consortium to define the epidemiology and outcomes of inpatient respiratory viral infections in pediatric hematopoietic stem cell transplant recipients. J Pediatr Infect Dis Soc. 2018;7:275–82.

4. Styczynski J, Czyzewski K, Wysocki M, Gryniewicz-Kwiatkowska O, Kolodziejczyk-Gietka A, Salamonowicz M, et al. Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study. Clin Microbiol Infect. 2016;22:179.e1–10.

5. Hutspardol S, Essa M, Richardson S, Schechter T, Ali M, Krueger J, et al. Significant transplantation-related mortality from respiratory virus infections within the first one hundred days in children after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2015;21:1802–7.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients;Blood Advances;2024-04-10

2. The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial;Clinical Infectious Diseases;2023-10-06

3. Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients;Current Opinion in Infectious Diseases;2023-09-20

4. Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances;Transplant Infectious Disease;2023-08-16

5. Vaccination practices in pediatric transplantation: A survey among member centers of the European reference network TransplantChild;Pediatric Transplantation;2023-08-05